C. L. Bennett

409 total citations
27 papers, 307 citations indexed

About

C. L. Bennett is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hematology. According to data from OpenAlex, C. L. Bennett has authored 27 papers receiving a total of 307 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Hematology. Recurrent topics in C. L. Bennett's work include Tuberculosis Research and Epidemiology (4 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers) and Neutropenia and Cancer Infections (4 papers). C. L. Bennett is often cited by papers focused on Tuberculosis Research and Epidemiology (4 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers) and Neutropenia and Cancer Infections (4 papers). C. L. Bennett collaborates with scholars based in United States. C. L. Bennett's co-authors include JO Armitage, Jamés O. Armitage, P. J. Bierman, J R Anderson, Julie M. Vose, Spencer Knight, Arthur S. Elstein, Elizabeth A. Calhoun, Robert A. Weinstein and Teresa M. Waters and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Respiratory and Critical Care Medicine and Stem Cells.

In The Last Decade

C. L. Bennett

24 papers receiving 294 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. L. Bennett United States 10 89 79 59 58 57 27 307
K Moeremans Belgium 11 43 0.5× 84 1.1× 56 0.9× 29 0.5× 41 0.7× 36 386
Thierry Lobbedez France 10 25 0.3× 60 0.8× 39 0.7× 55 0.9× 50 0.9× 51 441
Julie Priest United States 12 49 0.6× 38 0.5× 46 0.8× 20 0.3× 62 1.1× 26 375
Anita Feller Switzerland 15 64 0.7× 181 2.3× 30 0.5× 58 1.0× 114 2.0× 35 503
George J Joseph United States 15 147 1.7× 40 0.5× 104 1.8× 86 1.5× 51 0.9× 25 537
Ila M. Saunders United States 12 74 0.8× 112 1.4× 17 0.3× 75 1.3× 69 1.2× 47 360
Lena E. Winestone United States 14 114 1.3× 144 1.8× 41 0.7× 239 4.1× 50 0.9× 71 570
Gayathri Sridhar United States 11 94 1.1× 24 0.3× 21 0.4× 58 1.0× 50 0.9× 27 378
Alexis Zebrowski United States 9 68 0.8× 159 2.0× 27 0.5× 86 1.5× 27 0.5× 41 363
Sally Tan United States 10 20 0.2× 97 1.2× 47 0.8× 41 0.7× 40 0.7× 19 331

Countries citing papers authored by C. L. Bennett

Since Specialization
Citations

This map shows the geographic impact of C. L. Bennett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. L. Bennett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. L. Bennett more than expected).

Fields of papers citing papers by C. L. Bennett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. L. Bennett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. L. Bennett. The network helps show where C. L. Bennett may publish in the future.

Co-authorship network of co-authors of C. L. Bennett

This figure shows the co-authorship network connecting the top 25 collaborators of C. L. Bennett. A scholar is included among the top collaborators of C. L. Bennett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. L. Bennett. C. L. Bennett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Grimm, Sean, Alfred Rademaker, Laurie Rice, et al.. (2011). Quality-of-life concordance between patients with malignant gliomas and their caregivers: Updated data.. Journal of Clinical Oncology. 29(15_suppl). 9053–9053. 1 indexed citations
3.
Grimm, Sean, Alfred Rademaker, Laurie Rice, et al.. (2011). Financial burden experienced by patients undergoing treatment for malignant gliomas: Updated data.. Journal of Clinical Oncology. 29(15_suppl). e19571–e19571. 1 indexed citations
4.
Chia, Y., et al.. (2010). Quality of published studies supporting off-label and accelerated approval oncology indications.. Journal of Clinical Oncology. 28(15_suppl). 6059–6059.
5.
Carson, Kenneth R., Andrew M. Evens, Leo I. Gordon, et al.. (2008). Rituximab and progressive multifocal leukoencephalopathy: A report of 35 cases. Journal of Clinical Oncology. 26(15_suppl). 8531–8531. 1 indexed citations
6.
Bennett, C. L., June M. McKoy, D. Mark Courtney, et al.. (2008). Tumor progression and mortality associated with administration of erythropoiesis stimulating agents (ESAs) to cancer patients: Is toxicity due to ESAs or elevated hemoglobin (Hgb) levels. Journal of Clinical Oncology. 26(15_suppl). 11115–11115.
7.
Slimack, Nicholas P., Stephen A. Klinge, Steve Trifilio, et al.. (2004). Gemcitabine-associated interstitial pneumonitis: Comprehensiveness and clinical characteristics of FDA and medical literature cases. Journal of Clinical Oncology. 22(14_suppl). 7229–7229. 1 indexed citations
8.
Tarantolo, Stefano, et al.. (2000). Economic analysis of a phase III study of G-CSF vs placebo following allogeneic blood stem cell transplantation. Bone Marrow Transplantation. 26(6). 663–666. 20 indexed citations
9.
Thrasher, J. Brantley, et al.. (2000). Comparative study of the clinical efficacy of two dosing regimens of flutamide.. PubMed. 4(3). 259–63;discussion 265. 9 indexed citations
10.
Bennett, C. L., Anne Kessinger, Kevin M. Turner, et al.. (1999). Costs of care associated with high-dose therapy and autologous transplantation for non-Hodgkin’s lymphoma: results from the University of Nebraska Medical Center 1989 to 1995. Bone Marrow Transplantation. 24(6). 679–684. 20 indexed citations
11.
Arozullah, Ahsan M., Russell Bennett, Sander L. Gilman, et al.. (1999). Racial variation in the use of laparoscopic cholecystectomy in the Department of Veterans Affairs Medical System. Journal of the American College of Surgeons. 188(6). 604–622. 29 indexed citations
12.
Bennett, C. L., et al.. (1999). Valuing clinical strategies early in development: a cost analysis of allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplantation. 24(5). 555–560. 38 indexed citations
13.
Calhoun, Elizabeth A. & C. L. Bennett. (1999). Pharmacoeconomics of amifostine in ovarian cancer.. PubMed. 26(2 Suppl 7). 102–7. 9 indexed citations
14.
Bennett, C. L., Robert Golub, Elizabeth A. Calhoun, et al.. (1998). Cost-utility assessment of amifostine as first-line therapy for ovarian cancer. International Journal of Gynecological Cancer. 8(1). 64–72. 16 indexed citations
15.
Bennett, C. L., Gretchen B. Chapman, Arthur S. Elstein, et al.. (1997). A comparison of perspectives on prostate cancer: analysis of utility assessments of patients and physicians.. PubMed. 32 Suppl 3. 86–8. 27 indexed citations
16.
Bennett, C. L., JO Armitage, Julie M. Vose, et al.. (1995). Costs of care and outcomes for high-dose therapy and autologous transplantation for lymphoid malignancies: results from the University of Nebraska 1987 through 1991.. Journal of Clinical Oncology. 13(4). 969–973. 46 indexed citations
17.
Bennett, C. L., Ronnie D. Horner, David M. Aboulafia, & Robert A. Weinstein. (1995). Patterns of care for and outcomes of Pneumocystis carinii pneumonia among persons with transfusion‐acquired AIDS. Transfusion. 35(8). 674–678. 6 indexed citations
18.
Bennett, C. L., E.Z. Oddone, & David B. Matchar. (1995). Cost-effectiveness models of clinical trials of new pharmaceuticals for AIDS-related Pneumocystis carinii pneumonia: are they helpful to policy makers?. PubMed. 3(3). 156–64. 3 indexed citations
19.
Bennett, C. L., Robert A. Weinstein, Martin F. Shapiro, et al.. (1994). A Rapid Preadmission Method for Predicting Inpatient Course of Disease for Patients with HIV-Related Pneumocystis Carinii Pneumonia. American Journal of Respiratory and Critical Care Medicine. 150(6). 1503–1507. 37 indexed citations
20.
Gulati, Subhash C., et al.. (1993). GM‐CSF as an adjunct to autologous bone marrow transplantation. Stem Cells. 11(1). 20–25. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K Moeremans Breakdown of academic impact, for papers by Thierry Lobbedez Breakdown of academic impact, for papers by Julie Priest Breakdown of academic impact, for papers by Anita Feller Breakdown of academic impact, for papers by George J Joseph Breakdown of academic impact, for papers by Ila M. Saunders Breakdown of academic impact, for papers by Lena E. Winestone Breakdown of academic impact, for papers by Gayathri Sridhar Breakdown of academic impact, for papers by Alexis Zebrowski Breakdown of academic impact, for papers by Sally Tan
Rankless by CCL
2026